Literature DB >> 24798943

The genetics of functional disability in schizophrenia and bipolar illness: Methods and initial results for VA cooperative study #572.

Philip D Harvey1, Larry J Siever, Grant D Huang, Sumitra Muralidhar, Hongyu Zhao, Perry Miller, Mihaela Aslan, Shrikant Mane, Margaret McNamara, Theresa Gleason, Mary Brophy, Ronald Przygodszki, Timothy J O'Leary, Michael Gaziano, John Concato.   

Abstract

Given the prominence of cognitive impairments and disability associated with schizophrenia and bipolar disorder, substantial interest has arisen in identifying determinants of the diseases and their features. Genetic variation has been linked to skills that underlie disability ("functional capacity" or FC), highlighting need for understanding of these relationships. We describe the design and methods of a large, multisite, observational study focusing on the genetics of functional disability in schizophrenia and bipolar disorder, presenting initial data on recruitment, and characterization of the sample. Known as Veterans Affairs (VA) Cooperative Studies Program (CSP)#572, this study is recruiting, diagnosing, and assessing U.S. Veterans with either schizophrenia or bipolar I disorder. Assessments include neuropsychological (NP) testing, FC, suicidality, and co-morbid conditions such as posttraumatic stress disorder (PTSD). A sample of "psychiatrically healthy" Veterans from another project serves as a comparison group. An interim total of 8,140 participants (42.1% schizophrenia) have been recruited and assessed as of September 30, 2013, with 9 months of enrollment remaining and with a target sample size of 9,500. Veterans with schizophrenia were more likely to never have married, whereas lifetime PTSD and suicidality were more common in the bipolar veterans. Performance on the FC measures and NP tests was consistent with previous results, with mean t-scores of 35 (-1.5 SD) for schizophrenia and 41 (-0.9 SD) for the bipolar Veterans. This large population is representative of previous studies in terms of patient performance and co-morbidities. Subsequent genomic analyses will examine the genomic correlates of performance-based measures. Published 2014. This article is a U.S. Government work and is in the public domain in the USA. Published 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  bipolar; disability; genetics; neurocognition; schizophrenia

Mesh:

Year:  2014        PMID: 24798943     DOI: 10.1002/ajmg.b.32242

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  15 in total

1.  A Longitudinal Examination of the Moderating Effects of Symptoms on the Relationship between Functional Competence and Real World Functional Performance in Schizophrenia.

Authors:  Michael W Best; Maya Gupta; Christopher R Bowie; Philip D Harvey
Journal:  Schizophr Res Cogn       Date:  2014-06-01

2.  Factor structure of cognition and functional capacity in two studies of schizophrenia and bipolar disorder: Implications for genomic studies.

Authors:  Philip D Harvey; Mihaela Aslan; Mengtian Du; Hongyu Zhao; Larry J Siever; Ann Pulver; J Michael Gaziano; John Concato
Journal:  Neuropsychology       Date:  2016-01       Impact factor: 3.295

3.  Impact of genotyping errors on statistical power of association tests in genomic analyses: A case study.

Authors:  Lin Hou; Ning Sun; Shrikant Mane; Fred Sayward; Nallakkandi Rajeevan; Kei-Hoi Cheung; Kelly Cho; Saiju Pyarajan; Mihaela Aslan; Perry Miller; Philip D Harvey; J Michael Gaziano; John Concato; Hongyu Zhao
Journal:  Genet Epidemiol       Date:  2016-12-26       Impact factor: 2.135

4.  Factors influencing self-assessment of cognition and functioning in bipolar disorder: a preliminary study.

Authors:  Philip D Harvey; Gayla Paschall; Colin Depp
Journal:  Cogn Neuropsychiatry       Date:  2015       Impact factor: 1.871

5.  Absence of bias in clinician ratings of everyday functioning among African American, Hispanic and Caucasian patients with schizophrenia.

Authors:  Samir Sabbag; Davide Prestia; Belinda Robertson; Pedro Ruiz; Dante Durand; Martin Strassnig; Philip D Harvey
Journal:  Psychiatry Res       Date:  2015-07-02       Impact factor: 3.222

6.  Depression in Schizophrenia: Associations With Cognition, Functional Capacity, Everyday Functioning, and Self-Assessment.

Authors:  Philip D Harvey; Elizabeth W Twamley; Amy E Pinkham; Colin A Depp; Thomas L Patterson
Journal:  Schizophr Bull       Date:  2017-05-01       Impact factor: 9.306

7.  Depression predicts self assessment of social function in both patients with schizophrenia and healthy people.

Authors:  Lisa N Oliveri; Adam W Awerbuch; L Fredrik Jarskog; David L Penn; Amy Pinkham; Philip D Harvey
Journal:  Psychiatry Res       Date:  2019-11-06       Impact factor: 3.222

8.  Conducting clinical studies targeting cognition in psychiatry: guiding principles and design.

Authors:  Tamsyn E Van Rheenen; Kathryn E Lewandowski; Jessica M Lipschitz; Katherine E Burdick
Journal:  CNS Spectr       Date:  2018-09-24       Impact factor: 3.790

9.  Genome-Wide Association Studies of Schizophrenia and Bipolar Disorder in a Diverse Cohort of US Veterans.

Authors:  Tim B Bigdeli; Ayman H Fanous; Yuli Li; Nallakkandi Rajeevan; Frederick Sayward; Giulio Genovese; Rishab Gupta; Krishnan Radhakrishnan; Anil K Malhotra; Ning Sun; Qiongshi Lu; Yiming Hu; Boyang Li; Quan Chen; Shrikant Mane; Perry Miller; Kei-Hoi Cheung; Raquel E Gur; Tiffany A Greenwood; David L Braff; Eric D Achtyes; Peter F Buckley; Michael A Escamilla; Douglas Lehrer; Dolores P Malaspina; Steven A McCarroll; Mark H Rapaport; Marquis P Vawter; Michele T Pato; Carlos N Pato; Hongyu Zhao; Thomas R Kosten; Mary Brophy; Saiju Pyarajan; Yunling Shi; Timothy J O'Leary; Theresa Gleason; Ronald Przygodzki; Sumitra Muralidhar; J Michael Gaziano; Grant D Huang; John Concato; Larry J Siever; Mihaela Aslan; Philip D Harvey
Journal:  Schizophr Bull       Date:  2021-03-16       Impact factor: 9.306

10.  Cooperative Studies Program (CSP) #572: A Study of Serious Mental Illness in Veterans as a Pathway to personalized medicine in Schizophrenia and Bipolar Illness.

Authors:  Philip D Harvey; Tim B Bigdeli; Ayman H Fanous; Yuli Li; Nallakkandi Rajeevan; Frederick Sayward; Krishnan Radhakrishnan; Grant Huang; Mihaela Aslan
Journal:  Pers Med Psychiatry       Date:  2021-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.